4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-17-051986
10% owner disposed of 2,614,157 shares (other)
- 10% owner acquired 311,052 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital IV, L.P. 10% owner | 2017-09-05 | Other disposition | −1,368,013 | 2,736,032 | I | ||
| Versant Venture Capital IV, L.P. 10% owner | 2017-09-05 | Other disposition | −8,110 | 16,224 | I | ||
| Versant Venture Capital IV, L.P. 10% owner | 2017-09-05 | Other disposition | −814,599 | 1,629,204 | I | ||
| Versant Venture Capital IV, L.P. 10% owner | 2017-09-05 | Other disposition | −23,899 | 47,801 | I | ||
| Versant Venture Capital IV, L.P. 10% owner | 2017-09-05 | Other disposition | −61,993 | 123,994 | I | ||
| Versant Venture Capital IV, L.P. 10% owner | 2017-09-05 | Other disposition | −26,491 | 52,987 | I | ||
| Versant Venture Capital IV, L.P. 10% owner | 2017-09-05 | Other acquisition | +292,529 | 292,529 | I | ||
| Versant Venture Capital IV, L.P. 10% owner | 2017-09-05 | Other disposition | −292,529 | 0 | I | ||
| Versant Venture Capital IV, L.P. 10% owner | 2017-09-05 | Other acquisition | +17,283 | 17,283 | I | ||
| Versant Venture Capital IV, L.P. 10% owner | 2017-09-05 | Other disposition | −17,283 | 0 | I | ||
| Versant Venture Capital IV, L.P. 10% owner | 2017-09-05 | Other acquisition | +1,240 | 1,240 | I | ||
| Versant Venture Capital IV, L.P. 10% owner | 2017-09-05 | Other disposition | −1,240 | 0 | I |
Loading xslF345X03/doc4.xml…